Testing fatigue and muscle effects after starting targeted therapy
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how starting “targeted” treatment affects fatigue and skeletal muscle function in people with severe axial spondyloarthritis. It may help doctors understand what to expect early after treatment starts and how well it impacts day-to-day energy and muscle performance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have axial spondyloarthritis confirmed by the ASAS criteria
- You have not started targeted therapy yet (or started it within the last 15 days)
- Your doctor has decided you should start targeted therapy
- You’re at least 18 years old and can sign consent to join
- If you can get pregnant, your pregnancy test is negative and you use effective birth control
- You can understand French well enough to follow the study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people recently diagnosed with spondyloarthritis (a type of inflammatory arthritis) to understand how the disease changes over time. It aims to improve early detection and treatment.
This study follows patients with inflammatory arthritis (rheumatoid arthritis or spondyloarthritis) to learn more about how well biologic or targeted therapies work. If you have tried standard treatments without enough relief, this may help researchers improve future care.
This trial tests if a personalized home training program can help reduce severe fatigue in people with relapsing-remitting MS who were recently diagnosed. You'll use a phone app to do exercises designed for you, and researchers will check your energy levels over time.
This study is for people recently diagnosed with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine). It tests whether a standardized global review and education program can help patients better understand and manage their condition.
This study tests whether a supervised exercise program can help people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) who are already on biologic medications. It aims to see if exercise reduces inflammation and improves symptoms.
This trial tests a new oral medication that may reduce inflammation and improve symptoms in people with axial spondyloarthritis. It is in early phases, meaning the drug is still being studied for safety and effectiveness.
Hear when a new Fatigue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.